Influenza - Articles and news items

CHMP issues positive opinion of AstraZeneca’s pandemic influenza vaccine

Industry news / 5 April 2016 / Victoria White

This recommendation allows a vaccine containing a strain of pandemic potential to be developed and authorised in advance of a pandemic being declared…

FSA grants Fast Track designation for MEDI8852

Industry news / 7 March 2016 / Victoria White

MedImmune has received Fast Track designation from the FDA for MEDI8852 for the treatment of patients hospitalised with Type A strain influenza…

GSK submits sBLA seeking expanded indication for Flulaval Quadrivalent

Industry news / 3 February 2016 / Victoria White

The submission seeks an expanded indication for Flulaval Quadrivalent in the US for children six months through 35 months of age…

The universal flu vaccine race

Blog / 5 January 2016 / Victoria White, European Pharmaceutical Review

A number of pharmaceutical companies see great potential in a universal flu vaccine, each hoping they will be the first to gain regulatory approval of their candidates. European Pharmaceutical Review spoke with Gregory Stoloff, CEO of one such company, SEEK, to find out more…

SEEK’s universal flu vaccine is one step closer

Industry news / 12 November 2015 / Victoria White

FLU-v is a peptide-based vaccine that stimulates a cytotoxic T lymphocyte and non-neutralising antibody response against influenza. FLU-v may have potential as a cross-protective vaccine for multiple strains of influenza…

ESCMID calls for universal flu vaccination for healthcare works

Industry news / 4 November 2015 / Victoria White

ESCMID believes that one vital tool to increase the adoption of flu vaccinations among healthcare professionals is to establish hospital-based league tables throughout Europe…

GSK begins shipping 2015-16 US flu vaccines

Industry news / 17 July 2015 / Victoria White

GSK has begun shipping Flaurix Quadrivalent (flu vaccine) doses to US healthcare providers and expects to begin shipping Flulaval Quadrivalent in August…

Sanofi Pasteur ships first 2015-2016 seasonal influenza vaccine doses in US

Industry news / 14 July 2015 / Victoria White

The FDA has released the first doses of Sanofi Pasteur’s Fluzone influenza vaccine for shipment for the 2015-2016 influenza season in the US…

Flu shot

Flu vaccine shows low effectiveness against the main circulating strain seen so far this season

Industry news / 6 February 2015 / Public Health England

Flu vaccination remains important for other strains that still may circulate this winter…


France’s National Research Agency selects the OPTIVAC project and contributes €600,000 ($772,000) to improve the efficacy of influenza vaccines

Industry news / 27 October 2014 / Imaxio

Imaxio announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project ‘leveraging On t-cell immune resPonse To Improve influenza VACcines’…


Calixar and VirPath develop an innovative manufacturing process for high performance influenza vaccines

Industry news / 23 September 2014 / Andrew Lloyd & Associates

A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines…


European Medicines Agency invites comments on new overarching guidance for the development of influenza vaccines

Industry news / 31 July 2014 / The European Medicines Agency

The European Medicines Agency has released the second module of a new overarching guideline on influenza vaccines for a six-month public consultation…

  • Page 1 of 2
  • 1
  • 2
  • >


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...